Thombotic Microangiopathy in Myeloma Patients Receiving Carfilzomib, Cyclophosphamide and Dexamethasone
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Haematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Thrombotic Microangiopathy in Untreated Myeloma Patients Receiving Carfilzomib, Cyclophosphamide and Dexamethasone on the CARDAMON Study
Br. J. Haematol 2021 Mar 01;[EPub Ahead of Print], M Camilleri, M Cuadrado, E Phillips, W Wilson, R Jenner, G Pang, S Kamora, M Streetly, R Popat, C Bygrave, R Owen, J Cavenagh, M Chapman, J Sive, L Eccersley, M Sheaff, R Benjamin, K Ramasamy, G Cook, A Virchis, SJ Chavda, L Clifton-Hadley, MA Scully, K YongFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.